AzTrials
AzTrials

Crowding, ToothNCT05416242

Patient-centered Outcomes During Using Self-ligating Brackets With or Without Piezocision vs Traditional Brackets

A study testing Traditional braces, Self-ligating braces and Self-ligating braces + piezocision in people with Crowding, Tooth, run by Damascus University at 1 site in Syria.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The different types of brackets (e.g., self-ligating and conventional brackets), and the various acceleration methods (e.g., corticotomy) cause varying degrees of pain and discomfort. Read more about this study

Who is it for?
Ages 18 to 28 years
Conditions the study is for
Crowding, Tooth
What is being tested?
Traditional braces, Self-ligating braces and Self-ligating braces + piezocision
Could I receive a placebo?
No, everyone receives an active treatment
How many people
63 participants
Where
1 siteSyria
Study dates
14 Apr 2019to 22 Aug 2021
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 28 years
  • All sexes
  • No healthy volunteers
  • Adult

Who may be able to join

  • The patient's age is between 18 and 25 years
  • Severe crowding on the upper jaw (more than 6 mm) requires upper first premolars extraction
  • Little's Index of Irregularity is greater than 7 mm
  • Overbite ranging between 0-4 mm
  • Normal inclination of the upper incisors
  • No missing teeth (except for third molars)
  • Class I or class II (ANB ≤ 5) or class III (ANB ≥ 0)

Who cannot join

  • The presence of any systemic disease affecting orthodontic movement
  • The presence of congenital syndromes or cleft lip and palate
  • Poor oral health with a plaque index greater than (1)
  • Skeletal maxillary constriction

Trial locations and contacts

1 site in 1 country.

Syria1 site
  • University of Damascus

    Damascus

Other trials in Syria

About this study

Official title: Evaluation of Patient-centered Outcomes Associated With Acceleration of Lower Incisors Decrowding Using Self-ligating Brackets With and Without Piezocision in Comparison With Traditional Brackets: A Randomized Controlled Clinical Trial

The different types of brackets (e.g., self-ligating and conventional brackets), and the various acceleration methods (e.g., corticotomy) cause varying degrees of pain and discomfort. This study will assess pain, discomfort, and other patient-centered outcomes in adults with severe crowding on the upper jaw requiring two first premolars extraction.

There are three groups:

Read more

The first group (control group): the patients in this group will be treated using conventional brackets alone.

The second group (Experimental group): the patients in this group will be treated using self-ligating brackets alone.

The third group (Experimental group): the patients in this group will be treated using self-ligating brackets associated with flapless corticotomy.

Read the detailed description

Pain associated with orthodontic treatment is one of the undesirable complications, which negatively affects the patient's cooperation. Pain may occur due to the pressure on the periodontal ligaments induced by orthodontic forces. The perception of pain is affected by many factors related to the patient, such as age, gender and any previous treatment experiences, which are negatively or positively reflected on the patient's cooperation. As for the factors related to the type of orthodontic treatment provided, the pain and discomfort are proportional to the brackets system used and the forces applied, especially in the leveling and alignment stage. The amount of tooth movement is directly affected by the friction between the brackets and the wires used. The physical properties of the wire and brackets used and the dimensions of the applied wires, in addition to the type of ligation play a significant role in the amount of friction generated.

Conditions
Crowding, Tooth
Being tested
Traditional braces, Self-ligating braces, Self-ligating braces + piezocision
Keywords
Self-Ligating Brackets, Flapless corticotomy, Severe crowding, Leveling, Aligning
Medical subject headings
Malocclusion, Crowding

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Traditional bracesDevice

    MBT 0.022 perception traditional braces will be used without any acceleration method.

  • Self-ligating bracesDevice

    MBT 0.022 perception Self-ligating braces will be used without any acceleration method.

  • Self-ligating braces + piezocisionProcedure or surgery

    Flapless corticotomy will be applied for the upper anterior teeth.

Study groups in NCT05416242
Study groupRoleWhat they receive
Fixed applianceActive comparatorPatients in this group will be treated using traditional brackets alone.
Receives: Device: Traditional braces
Self-ligaton applianceExperimentalPatients in this group will be treated using self-ligating brackets alone.
Receives: Device: Self-ligating braces
Self-ligaton appliance + piezocisionExperimentalPatients in this group will be treated using self-ligating brackets associated with piezocision.
Receives: Procedure: Self-ligating braces + piezocision

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in the levels of pain

    Patients will be asked this question about their feeling of pain (Item no 01):

    'What is the degree of pain you have experienced?' A standardized questionnaire will be used to assess pain, discomfort and functional impairments' levels during the active phase of treatment. The patient will be asked to specify a point on the visual analogue scale (VAS), a 100-mm horizontal line with two focal points at its beginning and end (0: there is no pain - 100: the worst pain). The score will be determined by measuring the distance from the beginning until the point identified by the patient.

    Measured: After 24 hours; 4 days; 7 days; 14 days; 28 days

  2. Change in the levels of discomfort

    Patients will be asked this question about their feeling of discomfort (Item no 02):

    'What is the degree of discomfort you have experienced?' A standardized questionnaire will be used to assess pain, discomfort and functional impairments' levels during the active phase of treatment. The patient will be asked to specify a point on the visual analogue scale (VAS), a 100-mm horizontal line with two focal points at its beginning and end (0: there is no pain - 100: the worst pain). The score will be determined by measuring the distance from the beginning until the point identified by the patient.

    Measured: After 24 hours; 4 days; 7 days; 14 days; 28 days

  3. Change in the Perception of swelling

    Patients will be asked this question about their feeling of swelling (Item no 03):

    'What is the degree of swelling you have experienced?' A standardized questionnaire will be used to assess pain, discomfort and functional impairments' levels during the active phase of treatment. The patient will be asked to specify a point on the visual analogue scale (VAS), a 100-mm horizontal line with two focal points at its beginning and end (0: there is no pain - 100: the worst pain). The score will be determined by measuring the distance from the beginning until the point identified by the patient.

    Measured: After 24 hours; 4 days; 7 days; 14 days; 28 days

  4. Change in the difficulty of mastication

    'What is the degree of mastication difficulties you have experienced?' A standardized questionnaire will be used to assess pain, discomfort and functional impairments' levels during the active phase of treatment. The patient will be asked to specify a point on the visual analogue scale (VAS), a 100-mm horizontal line with two focal points at its beginning and end (0: there is no pain - 100: the worst pain). The score will be determined by measuring the distance from the beginning until the point identified by the patient.

    Measured: After 24 hours; 4 days; 7 days; 14 days; 28 days

  5. Change in the difficulty of swallowing

    Patients will be asked this question about their feeling of swallowing (Item no 05):

    'What is the degree of swallowing difficulties you have experienced?' A standardized questionnaire will be used to assess pain, discomfort and functional impairments' levels during the active phase of treatment. The patient will be asked to specify a point on the visual analogue scale (VAS), a 100-mm horizontal line with two focal points at its beginning and end (0: there is no pain - 100: the worst pain). The score will be determined by measuring the distance from the beginning until the point identified by the patient.

    Measured: After 24 hours; 4 days; 7 days; 14 days; 28 days

  6. Change in the perception of the jaw movement restriction

    Patients will be asked this question about their feeling of the jaw movement restriction (Item no 06):

    'What is the degree of the jaw movement restriction you have experienced?' A standardized questionnaire will be used to assess pain, discomfort and functional impairments' levels during the active phase of treatment. The patient will be asked to specify a point on the visual analogue scale (VAS), a 100-mm horizontal line with two focal points at its beginning and end (0: there is no pain - 100: the worst pain). The score will be determined by measuring the distance from the beginning until the point identified by the patient.

    Measured: After 24 hours; 4 days; 7 days; 14 days; 28 days

  7. The levels of satisfaction

    Patients will be asked this question about their levels of satisfaction (Item no 07): 'What is your levels of satisfaction on the orthodontic treatment provided?' A standardized questionnaire will be used to assess pain, discomfort and functional impairments' levels during the active phase of treatment. The patient will be asked to specify a point on the visual analogue scale (VAS), a 100-mm horizontal line with two focal points at its beginning and end (0: there is no satisfaction- 100: the highest satisfaction). The score will be determined by measuring the distance from the beginning until the point identified by the patient.

    Measured: This outcome will be assessed at 28 days following the beginning of treatment

  8. Recommendation of the procedure to a friend

    Patients will be asked this question (Item no 08): 'Would you recommend a friend undergo this treatment?' Assessment will be performed using a two-point scale to answer yes or no.

    Measured: This outcome will be assessed at 28 days following the beginning of treatment

  9. The possibility of repeating the procedure

    Patients will be asked this question about the possibility of repeating the procedure (Item no 09): 'Would you accept to undergo this treatment again?' Assessment will be performed using a two-point scale to answer yes or no.

    Measured: This outcome will be assessed at 28 days following the beginning of treatment

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted13 Jun 2022
  2. Study start14 Apr 2019
  3. Primary completion7 Oct 2020
  4. Study completion22 Aug 2021

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
63 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05416242
Sponsor's protocol ID
UDDS-Ortho-11-2022
Status last verified
Jun 2022
First submitted
5 Jun 2022
Last updated
14 Jun 2022
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Jahanbin A, Hasanzadeh N, Khaki S, Shafaee H. Comparison of self-ligating Damon3 and conventional MBT brackets regarding alignment efficiency and pain experience: A randomized clinical trial. J Dent Res Dent Clin Dent Prospects. 2019 Fall;13(4):281-288. doi: 10.15171/joddd.2019.043.

    PubMed 32190212
  • Fleming PS, Dibiase AT, Sarri G, Lee RT. Pain experience during initial alignment with a self-ligating and a conventional fixed orthodontic appliance system. A randomized controlled clinical trial. Angle Orthod. 2009 Jan;79(1):46-50. doi: 10.2319/121007-579.1.

    PubMed 19123718
  • Gibreal O, Hajeer MY, Brad B. Evaluation of the levels of pain and discomfort of piezocision-assisted flapless corticotomy when treating severely crowded lower anterior teeth: a single-center, randomized controlled clinical trial. BMC Oral Health. 2019 Apr 16;19(1):57. doi: 10.1186/s12903-019-0758-9.

    PubMed 30991984
  • Lai TT, Chiou JY, Lai TC, Chen T, Wang HY, Li CH, Chen MH. Perceived pain for orthodontic patients with conventional brackets or self-ligating brackets over 1 month period: A single-center, randomized controlled clinical trial. J Formos Med Assoc. 2020 Jan;119(1 Pt 2):282-289. doi: 10.1016/j.jfma.2019.05.014. Epub 2019 Jun 14.

    PubMed 31208826
  • Tecco S, D'Attilio M, Tete S, Festa F. Prevalence and type of pain during conventional and self-ligating orthodontic treatment. Eur J Orthod. 2009 Aug;31(4):380-4. doi: 10.1093/ejo/cjp003. Epub 2009 May 22.

    PubMed 19465738

Questions about this trial

What is this clinical trial studying?

A study testing Traditional braces, Self-ligating braces and Self-ligating braces + piezocision in people with Crowding, Tooth, run by Damascus University at 1 site in Syria.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 7 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 14 Jun 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Syria. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in the levels of pain (time frame: After 24 hours; 4 days; 7 days; 14 days; 28 days). The study lists 9 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT05416242, which also lists 5 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 14 Jun 2022.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in